FDA NDC Directory · JSON-LD · Markdown
NDC 71225-140 · HUMAN PRESCRIPTION DRUG · SUSPENSION
| Labeler / Manufacturer | Slayback Pharma LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA217252 |
| Dosage form / route | SUSPENSION · ORAL |
| Active ingredients | BACLOFEN (5 mg/mL) |
| Marketing started | 20230619 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).